Safety and Efficacy of Ranibizumab in Japanese Patients With Subfoveal Choroidal Neovascularization Secondary to Age-related Macular Degeneration

Clinical trial NCT00284089 · COMPLETED

Trial details

NCT number: NCT00284089
Sponsor: Novartis
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Subfoveal Choroidal Neovascularization(CNV) Secondary to Age-related Macular Degeneration (AMD)

Start date: 2005-04-01
Primary completion: 2007-03-01
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.